Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Bristol-Myers Squibb’s new facility is a part of a $40 billion commitment the company pledged to invest in research and development, technology and domestic manufacturing | Image Courtesy of Bristol-Myers Squibb

BMS Bets on Flexible Capacity With $2.3B Texas Campus

ByZachary Zubulake

August 10th 2026

Copenhagen city skyline in Denmark at famous old Nyhavn port | Image Credit: ©f11photo -stock.adobe.com

Danish Biotechs Attracting Investor Attention

ByCheryl Barton

August 10th 2026

PharmTech Weekly Roundup—August 7, 2026

BySusan Haigney

August 7th 2026

From Warehouse to Lakehouse: A Life Sciences Playbook for Regulated, AI-Ready Data Modernization

ByPartha S. Anbil,Deepak Manjarekar

August 7th 2026

melanoma diagnosis. the doctor examines the patient's mole | Image Credit: ©Evgeniy Kalinovskiy -stock.adobe.com

The FDA Gives Accelerated Approval to Melanoma Treatment

BySusan Haigney

August 7th 2026

Emerging Research Opportunities in Oral Inhalation Technology

Articles in this issue

Related Content

BMS Bets on Flexible Capacity With $2.3B Texas Campus

Danish Biotechs Attracting Investor Attention

PharmTech Weekly Roundup—August 7, 2026

From Warehouse to Lakehouse: A Life Sciences Playbook for Regulated, AI-Ready Data Modernization

The FDA Gives Accelerated Approval to Melanoma Treatment

Trending on Pharmaceutical Technology

What Does Moderna's mRNA Flu Vaccine Approval Signal?

Danish Biotechs Attracting Investor Attention

BMS Bets on Flexible Capacity With $2.3B Texas Campus

Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem

The FDA Gives Accelerated Approval to Melanoma Treatment